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O B J E C T I V E S We studied associations of magnetic resonance imaging measurements of plaque
area and relative percent lumen reduction in the proximal superﬁcial femoral artery with functional
performance among participants with peripheral arterial disease.
B A C KG ROUND The clinical signiﬁcance of directly imaged plaque characteristics in lower
extremity arteries is not well established.
METHOD S A total of 454 participants with an ankle brachial index 1.00 underwent magnetic
resonance cross-sectional imaging of the proximal superﬁcial femoral artery and completed a 6-min walk
test, measurement of 4-m walking velocity at usual and fastest pace, and measurement of physical
activity with a vertical accelerometer.
R E S U L T S Adjusting for age, sex, race, body mass index, smoking, statin use, comorbidities, and
other covariates, higher mean plaque area (1st quintile [least plaque]: 394 m, 2nd quintile: 360 m, 3rd
quintile: 359 m, 4th quintile: 329 m, 5th quintile [greatest plaque]: 311 m; p trend 0.001) and smaller
mean percent lumen area (1st quintile [greatest plaque]: 319 m, 2nd quintile: 330 m, 3rd quintile: 364 m,
4th quintile: 350 m, 5th quintile: 390 m; p trend 0.001) were associated with shorter distance achieved
in the 6-min walk test. Greater mean plaque area was also associated with slower usual-paced walking
velocity (p trend  0.006) and slower fastest-paced 4-m walking velocity (p trend  0.003). Associations
of mean plaque area and mean lumen area with 6-min walk distance remained statistically signiﬁcant
even after additional adjustment for the ankle brachial index and leg symptoms.
CONC L U S I O N S Among participants with peripheral arterial disease, greater plaque burden and
smaller lumen area in the proximal superﬁcial femoral artery are associated independently with poorer
functional performance, even after adjusting for the ankle brachial index and leg symptoms. (J Am Coll
Cardiol Img 2011;4:730–9) © 2011 by the American College of Cardiology Foundation
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731igh-resolution magnetic resonance imaging
(MRI) has emerged as a promising modality
for direct atherosclerotic plaque imaging
(1,2). However, little is known about associ-
tions of MRI-measured plaque area or lumen area
ith functional impairment in peripheral arterial dis-
ase (PAD). We used MRI to directly image cross
ections of the superficial femoral artery (SFA) (Fig. 1).
e studied associations of plaque area and percent
umen area in the SFA with functional impairment in
AD. We hypothesized that greater plaque area and
maller percent lumen area in the SFA would be
ssociated with greater functional impairment, inde-
endently of age, comorbidities, and other potential
onfounders. We also hypothesized that significant
ssociations of more adverse plaque characteristics
ith greater functional impairment would be elimi-
ated after additional adjustment for the ankle bra-
hial index (ABI).
M E T H O D S
Subjects. Participants were identified from among
consecutive PAD patients in the noninvasive vas-
cular laboratories at Northwestern Memorial Hos-
pital and 3 other Chicago-area medical centers.
Participants were also identified from among lists of
consecutive patients with a diagnosis of PAD in the
vascular surgery, cardiology, endocrinology, general
medicine, and geriatric practices at Northwestern
Medical Faculty Foundation and in the vascular
surgery practice at the Jesse Brown VA Medical
Center. A small number of participants were iden-
tified from among men and women age 70 years
and older in Northwestern’s largest general internal
Northwestern University Feinberg School of Medicine, Chicago, Illinois
Feinberg School of Medicine, Chicago, Illinois; Division of Vascular S
Medicine, Chicago, Illinois; ¶Surgical Services, Jesse Brown Veterans A
Cardiovascular Surgeons, Rush University Medical Center, Chicago,
University Medical Center, Chicago, Illinois; ††Department of Surgery,
ment of Biomedical Engineering and Radiology, Northwestern Unive
Research and Policy, Stanford University School of Medicine, Stanford,
edicine, University of California at San Diego, San Diego, California
ranch, National Institute on Aging, Bethesda, Maryland; ##Departmen
aryland School of Medicine, Baltimore, Maryland; ***Department of Ra
niversity of Washington, Seattle, Washington; †††Department of Radio
eattle, Washington; ‡‡‡Department of Radiology and Medicine, Un
irginia; and the §§§Department of Medicine, University of Texas Sou
urrently affiliated with the Department of Radiology and Bioenginee
alifornia. Supported by funding from the National Heart, Lung, and B
esearch Program of the National Institute on Aging, and by the Jesse Br
upport from VP Diagnostics and from Philips Healthcare. Dr. Kramer rec
u is a technical consultant for VP Diagnostics and owner of Imaging B
hat they have no relationships to disclose. Eike Nagel, MD, PhD, serveanuscript received October 29, 2010; revised manuscript received March 2medicine practice who were screened with the ABI
and found to have an ABI 1.00 (Fig. 2). To
maximize comparability with participants with pre-
viously established PAD, a minimum age of 70
years was required for participants identified in
general medicine. The protocol was approved by
the Institutional Review Boards of Northwestern
University Feinberg School of Medicine and all
participating sites. Participants gave written in-
formed consent.
Inclusion criteria. The inclusion criterion was an
ABI 1.00. This inclusion criterion was selected
because truly normal ABI values are 1.10 to 1.40
(3–5) and because including participants with ABI
1.00 ensured a broad range of severity of lower
extremity atherosclerosis. Presence of intermittent
claudication was not an inclusion criterion.
Exclusion criteria. Potential participants with de-
entia and those with a Mini-Mental Status Exam-
nation score23 (6) were excluded. Nursing home
esidents, wheelchair-bound patients, and patients
ith foot or leg amputations were ex-
luded because of their severely impaired
unctioning. Non–English-speaking pa-
ients were excluded because investigators
ere not fluent in non-English languages.
e excluded potential participants who
equired oxygen therapy, had contraindi-
ations to MRI testing, stopped the 6-min
alk test due to shortness of breath, had
ecent major surgery, or had severe knee
steoarthritis. Severe arthritis was defined
ased on the presence of radiograph-
easured osteoarthritis Kellgren-Lawrence score of 4
mong participants who reported pain in or around
epartment of Surgery, Northwestern University
ry, Northwestern University Feinberg School of
Medical Center, Chicago, Illinois; #University
ois; **Department of Vascular Surgery, Rush
unt Sinai Hospital, Chicago, Illinois; ‡‡Depart-
, Evanston, Illinois; §§Department of Health
ifornia;  Department of Family and Preventive
Longitudinal Studies Section, Clinical Research
Epidemiology and Public Health, University of
ogy, Electrical Engineering, and Bioengineering,
, University of Washington School of Medicine,
ity of Virginia Health System, Charlottesville,
estern Medical Center, Dallas, Texas. Dr. Li is
, Cedars Sinai Medical Center, Los Angeles,
Institute (R01-HL083064), by the Intramural
VA Medical Center. Dr. Yuan receives research
s research support from Siemens Healthcare. Dr.
arker Solutions. All other authors have reported
Guest Editor for this article.
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732their knee(s) on most days (7). All participants who
reported pain in or around their knees on most days
underwent a knee radiograph. Potential participants
with bilateral superficial femoral artery stents were
excluded, because the stents interfered with plaque
imaging. Individuals with aortoiliac disease and those
taking cilostazol were not excluded.
Ankle brachial index measurement. After partici-
ants rested supine for 5 min, a handheld Doppler
robe (Nicolet Vascular Pocket Dop II, Golden,
olorado) was used to measure systolic pressures in
his order: right brachial, dorsalis pedis, and poste-
ior tibial arteries and left dorsalis pedis, posterior
ibial, and brachial arteries. Pressures were repeated
n reverse order. The ABI was calculated in each leg
y dividing average pressures in each leg by the
verage of the 4 brachial pressures (8). Average
rachial pressures in the arm with highest pressure
ere used when 1 brachial pressure was higher than
Figure 1. Location of SFA Imaging
Twelve 2.5-mm cross-sectional images were obtained from the
proximal superﬁcial femoral artery (SFA). The bifurcation of
the common femoral artery was used as a landmark to deﬁne
the start of the SFA. Figure illustration by Craig Skaggs.he opposite brachial pressure in both measurement pets, and when the 2 brachial pressures differed by
0 mm Hg or more in at least 1 measurement set,
ecause in such cases, subclavian stenosis was pos-
ible (9). Data from undetectable or incompressible
orsalis pedis and posterior tibial arteries were
xcluded from the ABI calculation. However, none
f the participants had both undetectable dorsalis
edis and posterior tibial pressures in 1 leg, and no
otential participants were excluded because of
ndetectable dorsalis pedis or posterior tibial pres-
ures. Limbs with noncompressible vessels in both
he dorsalis pedis and posterior tibial vessels were
xcluded from analyses.
Magnetic resonance imaging. We imaged the SFA
ecause it is the most common site of lower
xtremity atherosclerosis (10,11) and because it
upplies the calf muscle, which is typically symp-
omatic in patients with PAD. The leg with lowest
BI was imaged. However, if the leg with the
owest ABI had an SFA stent, the opposite leg was
maged. MRI data were obtained with a 1.5-T
Siemens, Malvern, Pennsylvania) platform using
-element phased-array surface coils. We imaged
he proximal region of the SFA because its super-
cial location was more amenable to high quality
mages than the distal SFA was. The bifurcation of
he common femoral artery served as the reference
oint. Twelve consecutive 2.5-mm cross-sectional
mages were obtained, moving distally from the
ost proximal point of the SFA, using
-dimensional bright blood time-of-flight and
roton-density weighted images. Fat suppression
as applied in black-blood sequences to improve
mage quality. This method has excellent test–retest
eliability (12).
CASCADE software (Cascade Software Corpo-
ation, Seattle, Washington) was used by 2
hysician-reviewers to trace the outer boundary and
he lumen of each cross-sectional image of the SFA.
ASCADE software quantified the plaque area
ased on the tracings. Plaque measurements were
ormalized for artery size (13). Specifically, for each
articipant, the measured mean and maximum plaque
rea were divided by the median of the outer wall area.
o normalize lumen area measures, the mean and
inimum lumen area were dividing by the outer wall
rea at each site. This normalization allowed us to take
nto account the fact that a given plaque size may have
different impact on study outcomes, depending on
he size of the artery. Each reported plaque measure is
ormalized using these methods.
Images for each participant were assigned to arimary reviewer, and arterial tracings were re-
nda
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 4 , N O . 7 , 2 0 1 1
J U L Y 2 0 1 1 : 7 3 0 – 9
McDermott et al.
Plaque and Function in PAD
733viewed by the second reviewer to ensure accuracy.
In addition, independent readings by the 2 review-
ers of the same artery were compared. The coeffi-
cient of variation percent values for these test
inter-rater reliability assessments were 2.11 for
mean plaque area, 4.24 for maximum plaque area,
1.77 for mean percent lumen reduction, and 1.77
for maximum percent lumen reduction.
A 6% subsample of participants returned on a
second day for test–retest reliability assessment of
MRI measurements. The coefficient of variation
percent values for these test–retest reliability assess-
ments were 5.8 for mean plaque area, 8.9 for
maximum plaque area, 7.9 for mean percent lumen
area, and 12.9 for minimum percent lumen area.
Functional Measures
Six-minute walk. Participants walk up and down a
100-foot hallway for 6 min with instructions to
cover as much distance as possible (14,15). The
distance walked at the end of 6 min was recorded.
The intraclass correlation coefficient for test–retest
reliability of the 6-min walk was 0.90 (p  0.001)
among 155 PAD participants in our laboratory who
Figure 2. Representative Images of 2 Participants With Mild an
Images from a participant with minimal plaque (A,B) and from a pa
resonance images (A,C) (repetition time/echo time [TR/TE]  2,160
were used to deﬁne the outer (blue contour) and inner lumen boucompleted 2 tests 1 to 2 weeks apart (15).Four-meter walking velocity. Walking velocity
was measured with a 4-m walk performed at “usual”
and “fastest” paces, based on previous study (14). For
the usual-paced walk, participants were advised to
walk at a normal pace, as if they were “walking down
the street to go to the store.” For the fast-paced walk,
participants were advised to walk at their fastest speed.
Each walk was performed twice. The faster walk in
each pair was used in analyses (14).
Physical activity measurement. We used a vertical
accelerometer (Caltrac, Muscle Dynamics Fitness
Network Inc., Torrance, California) to measure phys-
ical activity continuously over 7 days using previously
described methods (16,17). The accelerometer was
programmed identically for all participants, allowing
us to compare physical activity levels between partic-
ipants, irrespective of individual variation in age,
weight, height, and sex (16,17). Programmed in this
way, the accelerometers measured “activity units.”
Comorbidities. Algorithms developed for the
Women’s Health and Aging Study and the Cardiovas-
cular Health Study were used to document comorbidities
(18). These algorithms combine data from patient report,
physical examination, medical record review, medica-
tions, laboratory values, and a primary care physician
vere PAD
pant with substantial plaque (C,D). Proton-weighted magnetic
8 ms) and time of ﬂight images (B,D) (TR/TE  38 ms/8.7 ms)
ries (red contour), respectively. PAD  peripheral arterial disease.d Se
rtici
ms/questionnaire (18). Comorbidities assessed were angina
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734pectoris, diabetes mellitus, myocardial infarction, stroke,
heart failure, pulmonary disease, cancer, spinal stenosis,
and disk disease. Criteria from the American College of
Rheumatology were used to diagnose knee and hip
osteoarthritis (9,19).
Leg symptoms. Leg symptoms were classified us-
ing the San Diego claudication questionnaire (20).
Intermittent claudication was defined as exertional
calf pain that does not begin at rest, causes the
participant to stop walking, and resolves within 10
min of rest. Participants without claudication were
either asymptomatic (i.e., no exertional leg symp-
toms) or had exertional leg symptoms not consis-
tent with claudication.
Other measures. Height and weight were mea-
sured at the study visit. Body mass index (BMI) was
calculated as weight/height (kg/m2). Cigarette
moking history was measured with self-report.
articipants brought their medication bottles or a
ist of medications to their study visit. Medication
ames were recorded. The study principal investi-
ator (M.M.M.) identified which participants were
aking statin medications, but was blinded to par-
icipant characteristics.
tatistical analyses. Quintiles of mean and maxi-
um plaque area and mean and minimum percent
Figure 3. Number of Excluded Individuals Among Those ContacABI  ankle brachial index; MR  magnetic resonance; PAD  peripheumen area in the SFA, respectively, were defined.
ifferences in continuous and dichotomous variables
ere compared across these quintiles using analyses of
ariance and chi-square tests, respectively. Six-min
alk performance, usual-paced and fastest-paced 4-m
alking velocity, and physical activity levels were
ompared across quintiles of each plaque measure
sing analyses of covariance, adjusting for age, race, sex,
moking, BMI, statins, and comorbidities (model 1).
hese analyses were repeated with additional ad-
ustment for the ABI (model 2). Model 2 was
epeated adding adjustment for leg symptoms
model 3). For each plaque characteristic, pairwise
omparisons were made between the lowest quintile
nd each of the remaining 4 quintiles.
With 454 PAD participants, this study had 80%
ower to detect a minimum partial correlation coeffi-
ient of 0.14 between 2 continuous measures, based
n a 2-sided test at the significance level of 0.05.
nalyses were performed using SAS statistical soft-
are (version 9.0, SAS Inc., Cary, North Carolina).
R E S U L T S
Figure 3 shows participation and exclusion rates
among potential participants contacted for study. Of
for Study Participationtedral arterial disease.
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7353,391 men and women with PAD who received a
recruitment letter, 1,161 did not respond. Of the
remainder, 504 met 1 or more exclusion criteria, 954
refused participation, and 304 could not be scheduled
or did not show for their study visit, leaving 468 PAD
participants. An additional 4 PAD participants were
identified from among patients in the general internal
medicine practice who were screened with the ABI
(Fig. 3). Of these 473 PAD participants, 16 had poor
quality MR images and 3 were missing data for
covariates, leaving 454 PAD participants.
Greater mean plaque area and smaller mean
percent lumen area were each associated with older
age, lower ABI values, higher prevalences of inter-
mittent claudication, and lower prevalences of
asymptomatic PAD (Table 1).
Adjusting for age, sex, race, smoking, BMI, statin
use, and comorbidities, higher mean plaque area was
associated with shorter distance achieved in the 6-min
Table 1. Associations of Baseline Characteristics With Plaque Ar
Norm
Quintile 1
(0.38–0.56)
(n  90)
Quinti
(0.56–0
(n  9
Age, yrs 65.2 11.0 69.6
Male 62.22 65.9
Black race 36.7 29.7
Ankle brachial index 0.76 0.15 0.70
Body mass index, kg/m2 30.7 6.8 29.3
Current smoking 23.3 26.4
Diabetes mellitus 38.9 50.6
Intermittent claudication 17.8 16.5
Asymptomatic 23.3 33.0
Leg symptoms other
than intermittent
claudication
58.9 50.5
M
Quintile 1
(0.00–0.22)
(n  90)
Quinti
(0.22–0
(n  9
Age, yrs 69.3 9.0 71.6
Male 66.7 63.7
Black race 42.2 28.6
Ankle brachial index 0.55 0.16 0.63
Body mass index, kg/m2 28.9 5.4 28.7
Current smoking 26.7 17.6
Diabetes mellitus 36.7 33.0
Intermittent claudication 38.9 25.3
Asymptomatic 8.9 14.3
Leg symptoms other
than intermittent
claudication
52.2 60.4
Values are mean  SD or %.
PAD  peripheral arterial disease.walk (p trend 0.001), slower usual-paced walking
velocity (p trend  0.006), and slower fastest-paced
alking velocity (p trend 0.002) (Table 2, model 1).
After additional adjustment for ABI, these associa-
tions were attenuated but remained statistically signif-
icant (Table 2, model 2). After additional adjustment
for leg symptoms, only associations of greater plaque
area with shorter 6-min walk distance and slower
rapid-paced 4-m walking velocity remained statisti-
cally significant (Table 2, model 3).
Adjusting for age, sex, race, smoking, BMI, statin
use, and comorbidities, higher maximum plaque area
was associated with shorter distance achieved in the
6-min walk (p trend 0.001), slower usual-paced
alking velocity (p trend 0.001), and slower fastest-
aced walking velocity (p trend  0.023) (Table 2,
odel 1). Associations of greater maximal plaque area
ith shorter 6-min walk distance and slower usual-
aced 4-m walking velocity remained statistically
and Percent Lumen Reduction in Participants With PAD
d Mean Vessel Plaque Area
Quintile 3
(0.62–0.68)
(n  91)
Quintile 4
(0.68–0.81)
(n  91)
Quintile
(0.81–1.44
(n  91)
71.5 9.9 71.2 9.5 69.0 9.0
65.9 67.0 67.0
29.7 28.6 40.7
0.71 0.16 0.61 0.15 0.56 0.1
28.9 5.6 28.7 6.7 28.8 5.3
26.4 20.9 25.3
33.0 36.3 34.1
20.9 25.3 36.3
24.2 14.3 6.6
54.9 60.4 57.1
n Percent Lumen Area
Quintile 3
(0.33–0.38)
(n  91)
Quintile 4
(0.38–0.44)
(n  91)
Quintile
(0.44–0.60
(n  91)
71.6 9.3 69.1 10.3 64.9 10.
73.6 61.5 62.6
24.2 36.3 34.1
0.70 0.17 0.71 0.17 0.76 0.1
28.5 5.6 29.7 5.6 30.5 6.6
25.3 29.7 23.1
37.4 46.2 39.6
22.0 13.2 17.6
19.8 37.4 20.9
58.2 49.5 61.5ea
alize
le 2
.62)
1)
5
) Trend
p Value
10.2 0.040
0.805
0.839
0.17 7 0.001
5.3 0.049
0.604
0.171
0.003
0.001
0.608
ea
le 2
.33)
1)
5
) Trend
p Value
9.9 8 0.008
0.916
0.343
0.15 5 0.001
6.6 0.057
0.980
0.357
0.001
0.001
0.860
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736Table 2. Associations of Plaque Characteristics With Functional Performance in Men and Women With PAD
Normalized Mean Plaque Area
Quintile 1
(0.38–0.56)
(n  90)
Quintile 2
(0.56–0.62)
(n  91)
Quintile 3
(0.62–0.68)
(n  91)
Quintile 4
(0.68–0.81)
(n  91)
Quintile 5
(0.81–1.44)
(n  91)
Trend
p Value
6-min walk, m Model 1 394.4* 360.3† 359.4† 328.9 311.2 .0001
Model 2 382.5† 355.7 352.4 336.5 326.4 0.001
Model 3 387.0† 361.5 360.0 350.5 338.3 0.004
Usual-paced 4-m walking velocity, m/s Model 1 0.92† 0.87 0.89 0.86 0.84 0.006
Model 2 0.92‡ 0.86 0.89 0.86 0.85 0.047
Model 3 0.92 0.87 0.90 0.88 0.87 0.092
Rapid-paced 4-m walking velocity, m/s Model 1 1.29† 1.22 1.21 1.17 1.17 0.002
Model 2 1.28‡ 1.22 1.21 1.18 1.18 0.029
Model 3 1.29‡ 1.23 1.22 1.20 1.20 0.030
Physical activity, activity units Model 1 811 827 749 683 733 0.087
Model 2 804 825 746 687 743 0.179
Model 3 817 845 770 725 782 0.360
Normalized Maximum Plaque Area
Quintile 1
(0.44–0.70)
(n  90)
Quintile 2
(0.70–0.78)
(n  91)
Quintile 3
(0.78–0.88)
(n  91)
Quintile 4
(0.88–1.05)
(n  91)
Quintile 5
(1.05–4.57)
(n  91)
Trend
p Value
6-min walk, m Model 1 389* 373† 341 331 320 .0001
Model 2 376‡ 367‡ 341 336 334 0.008
Model 3 377 375 350 350 347 0.032
Usual-paced 4-m walking velocity, m/s Model 1 0.91† 0.88 0.90 0.86 0.84 0.001
Model 2 0.90‡ 0.88 0.90 0.86 0.85 0.007
Model 3 0.91 0.89 0.90 0.88 0.86 0.017
Rapid-paced 4-m walking velocity, m/s Model 1 1.27‡ 1.24 1.21 1.16 1.17 0.023
Model 2 1.26 1.23 1.21 1.17 1.19 0.118
Model 3 1.27 1.24 1.23 1.19 1.20 0.158
Physical activity, activity units Model 1 869‡ 749 750 737 704 0.195
Model 2 863‡ 747 750 739 711 0.323
Model 3 860 774 775 779 750 0.655
Mean Percent Lumen Area
Quintile 1
(0.00–0.22)
(n  90)
Quintile 2
(0.22–0.32)
(n  91)
Quintile 3
(0.32–0.38)
(n  91)
Quintile 4
(0.38–0.44)
(n  91)
Quintile 5
(0.44–0.60)
(n  91)
Trend
p Value
6-min walk, m Model 1 319* 330* 364 350‡ 390 .0001
Model 2 338‡ 336‡ 358 344‡ 377 0.053
Model 3 349‡ 349‡ 366 237 228 0.110
Usual-paced 4-m walking velocity, m/s Model 1 0.85‡ 0.87 0.89 0.86‡ 0.91 0.047
Model 2 0.87 0.87 0.89 0.85 0.90 0.283
Model 3 0.88 0.89 0.89 0.87 0.91 0.426
Rapid-paced 4-m walking velocity, m/s Model 1 1.17† 1.17† 1.22 1.20‡ 1.28 0.006
Model 2 1.19 1.18‡ 1.22 1.20 1.27 0.069
Model 3 1.20 1.20 1.23 1.22 1.29 0.065
Physical activity, activity units Model 1 731 698 773 803 803 0.135
Model 2 743 701 769 800 796 0.277
Model 3 778 738 788 829 813 0.448(Continued on next page)
hich 0.05.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 4 , N O . 7 , 2 0 1 1
J U L Y 2 0 1 1 : 7 3 0 – 9
McDermott et al.
Plaque and Function in PAD
737significant after additional adjustment for the ABI
(Table 2, model 2) and after additional adjustment
for leg symptoms (Table 2, model 3).
Adjusting for age, sex, race, smoking, BMI,
statin use, and comorbidities, lower mean percent
lumen area was associated with shorter distance
achieved in the 6-min walk (p trend 0.001),
slower usual-paced walking velocity (p trend 
0.047), and slower fastest-paced walking velocity
(p trend  0.006) (Table 2, model 1). However,
these associations were no longer significant after
additional adjustment for the ABI.
Adjusting for age, sex, race, smoking, BMI, statin
use, and comorbidities, smaller minimum percent
lumen area was associated with shorter distance
achieved in the 6-min walk (p trend 0.001), slower
usual-paced walking velocity (p trend  0.005),
slower fastest-paced walking velocity (p trend 
0.002), and lower physical activity (p trend  0.041)
(Table 2, model 1). After additional adjustment for
ABI, these associations remained statistically signifi-
cant for the 6-min walk, usual-paced 4-m walking
velocity, and fast-paced 4-m walking velocity (Table 2,
model 2). After additional adjustment for leg symp-
toms, only associations of minimum percent lumen
area with 6-min walk and rapid-paced 4-m walking
velocity remained statistically significant (Table 2,
model 3).
D I S C U S S I O N
Among 454 PAD participants, our findings dem-
Table 2. Continued
Qui
(0.0
(n
6-min walk, m Model 1 3
Model 2 3
Model 3 3
Usual-paced 4-m walking velocity, m/s Model 1 0
Model 2 0
Model 3 0
Rapid-paced 4-m walking velocity, m/s Model 1 1
Model 2 1
Model 3 1
Physical activity, activity units Model 1
Model 2
Model 3
Physical activity was measured over 7 days with a vertical accelerometer. Mod
myocardial infarction, stroke, heart failure, pulmonary disease, cancer, spinal ste
for covariates in model 2 and leg symptoms. The p trend tests the degree to wonstrate, for the first time, that greater mean andmaximum plaque area and smaller percent mini-
mum lumen area in the proximal SFA are associ-
ated significantly and independently with poorer
functional performance, even after adjusting for the
ABI. Prior work by Anderson et al. (13) demon-
strated that greater plaque area was associated with
poorer 6-min walk performance (r  –0.30) and
poorer maximum treadmill walking distance (r 
–0.32) in 85 participants with PAD. However, these
associations were not adjusted for confounders such as
age, comorbidities, or the ABI (13). Identifying char-
acteristics associated with the degree of functional
impairment in PAD is important because these asso-
ciations may provide clues to interventions that may
improve functional performance in PAD.
Although participants with aorto-iliac (inflow)
disease were included in the study, our results still
demonstrated that plaque area and lumen area in
the proximal superficial femoral artery were associ-
ated significantly with the degree of functional
impairment in PAD. Our results suggest that
plaque burden in the proximal superficial femoral
artery may be a sensitive measure of lower extremity
atherosclerotic disease burden, which in turn may
be related to functional performance.
Associations of mean and maximum plaque area
and minimum percent lumen area in the proximal
SFA with some measures of functional performance
remained statistically significant, even after adjust-
ment for the ABI. This finding indicates that some
associations of greater plaque area and smaller
Minimum Percent Lumen Area
1
08)
0)
Quintile 2
(0.08–0.22)
(n  91)
Quintile 3
(0.22–0.29)
(n  91)
Quintile 4
(0.29–0.36)
(n  91)
Quin
(0.36
(n 
333† 359 361 3
341 356 353 3
355 366 358 3
0.88 0.87 0.88 0
0.89 0.87 0.87 0
0.91 0.88 0.88 0
1.20 1.17‡ 1.26 1
1.21 1.17‡ 1.25 1
1.23 1.19 1.26 1
757 701 799 8
762 699 793 8
800 728 808 8
adjusts for age, sex, race, smoking, body mass index, statins, and comorbidities (
, and disk disease). Model 2 adjusts for covariates in model 1 and the ankle brach
associations across the plaque quintiles are linear. *p  0.001; †p  0.01; ‡p ntile
0–0.
 9
tile 5
–0.55)
91)
Trend
p Value
14* 86 .0001
29† 74 0.002
39‡ 80 0.007
.84† .91 0.005
.85‡ .90 0.044
.86 .91 0.090
.17‡ .26 0.002
.19 .25 0.032
.20 .26 0.033
725 27 0.041
736 19 0.092
771 39 0.217
el 1 angina, diabetes mellitus,
nosis ial index. Model 3 adjustspercent lumen area with greater functional perfor-
D
c
c
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 4 , N O . 7 , 2 0 1 1
J U L Y 2 0 1 1 : 7 3 0 – 9
McDermott et al.
Plaque and Function in PAD
738mance were independent of the ABI. The ABI is
influenced by medial arterial calcinosis and does not
change substantially over time, even as lower ex-
tremity perfusion deteriorates (21). Our findings
suggest that mean and maximum plaque area and
minimum percent lumen reduction may be better
measures of the imbalance between oxygen supply
and demand during walking than the resting ABI.
It is also important to point out that some associ-
ations of plaque measures with functional impair-
ment were further attenuated after additional ad-
justment for leg symptoms.
Glagov et al. (22) described the phenomenon of
expansive remodeling, in which atherosclerotic
plaque expands outwardly from the vessel wall,
possibly in an attempt to maintain arterial lumen
size as atherosclerosis develops. In our analyses,
mean and maximum plaque area were more consis-
tently associated significantly with impaired func-
tional performance than mean percent lumen area.
Our results suggest that for patients with PAD,
outward plaque growth may not be protective
against detrimental associations of lower extremity
atherosclerotic plaque with impaired functional per-
formance. However, expansive remodeling is most
protective in arteries with lesser percent lumen
reduction and may be less applicable to people with
established or more severe PAD (22).
Study limitations. First, our findings may not be
generalizable to PAD patients who did not meet
our inclusion criteria, including potential partici-
pants with contraindications to MRI testing. Only
8 participants had an ABI 0.30. Thus, are find-
ings are not generalizable to participants with crit-
ical limb ischemia. Second, we imaged the proximaltremities. Brit J Surg 1969;56:676–9. and reporting of osteble to MR imaging. The degree to which plaque
area and percent lumen area in the proximal super-
ficial femoral artery represent the degree of plaque
area or percent lumen reduction in other sections of
the SFA is unknown. Third, our methods did not
allow us to separate calcification from other aspects
of measured atherosclerotic plaque. Associations of
plaque area with functional performance may have
differed if our plaque area measurements excluded
calcification. Fourth, we did not collect data in all
participants on maximal stenosis of lower extremity
atherosclerosis in each limb. Thus, our data could
not be adjusted for this information.
C O N C L U S I O N S
This study demonstrates that greater plaque area
and smaller plaque lumen are associated with
greater functional impairment in participants with
PAD. Our results should not be interpreted as a
recommendation for additional or alternative diag-
nostic testing as compared with current clinical
practice in patients with PAD. Further study is
needed to determine whether plaque area and per-
cent lumen reduction in the proximal SFA are
associated with the degree of decline in functional
performance among participants with PAD. Fur-
ther study is also needed to determine whether
interventions that reverse plaque burden can im-
prove functional performance in PAD.
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